Superluminal Medicines (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- August 29, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $33,000,000
Company Info
- Organizations Involved
- Gaingels, Insight Partners, NVIDIA, RA Capital Management
- Founders
- Cony D'Cruz
- Company Description
- Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.
- Market
- Pharmaceuticals
- Location
- Boston, MA, USA
- Coinvestors
- Gaingels, Insight Partners, NVIDIA, RA Capital Management